A new fluorescent imaging of renal inflammation with RCP

Journal of Controlled Release

Volumn 148, Issue 3, 2010, Pages 351-358

  Nakamura, Kentaro ^a   Tabata, Yasuhiko ^b  

^a FUJIFILM CORPORATION   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Fluorescent imaging; Nephritis; Recombinant polymer; Renal inflammation; RGD

Indexed keywords

FLUORESCENT IMAGING; NEPHRITIS; RECOMBINANT POLYMERS; RENAL INFLAMMATION; RGD;

CELL MEMBRANES; GELS; PATHOLOGY; POLYMERS;

FLUORESCENCE;

ANTIBODY; ARGINYLGLYCYLASPARTIC ACID; COLLAGEN TYPE 1; FLUORESCENT DYE; INTEGRIN RECEPTOR; POLYMER; RECOMBINANT POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY ISCHEMIA; MALE; MOUSE; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NEPHRITIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN MOTIF; REPERFUSION INJURY;

ANIMALS; CARBOCYANINES; COLLAGEN TYPE I; EPITHELIAL CELLS; FLUORESCENCE; FLUORESCENT DYES; HUMANS; KIDNEY; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NEPHRITIS; OLIGOPEPTIDES; REPERFUSION INJURY;

EID: 78649779503     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.09.005     Document Type: Article

References (48)

1. K. Miyata, N. Nishiyama, and K. Kataoka Design of polymeric nanodevice for drug delivery system Oyo Butsuri 74 9 2005 1233 1237
2. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 1 2001 113 131
3. G. Gauchera, M.H. Dufresnea, V.P. Santa, N. Kanga, D. Maysingerb, and J.C. Lerouxa Block copolymer micelles: preparation, characterization and application in drug delivery J. Control. Release 109 2005 169 188
4. United States Renal Data System (USRDS) 2004 annual report Am. J. Kidney Dis. 45 2005
5. R.A. Hamer, and A.M. El Nahas The burden of chronic kidney disease BMJ 332 7541 2006 563 564
6. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diab. Care 21 9 1998 1414 1431
7. M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A.X. Garg Chronic kidney disease and mortality risk: a systematic review J. Am. Soc. Nephrol. 17 7 2006 2034 2047
8. C.J. Coester, K. Langer, H. van Briesen, and J. Kreuter Gelatin nanoparticles by two step desolvation - a new preparation method, surface modifications and cell uptake J. Microencapsul. 17 2 2000 187 193
9. T. Machiguchi, H. Yoshida, and T. Tamura Macrophage and platelet-infiltrated glomerulonephritis with interstitial angiofollicular hyperplasia in a patient with POEMS syndrome Nephrol. Dial. Transplant. 16 11 2001 2270 2271
10. G.F. Schreiner, K.P. Harris, M.L. Purkerson, and S. Klahr Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney Kidney Int. 34 4 1988 487 493
11. H. Kamada, Y. Tsutsumi, K. Sato-Kamada, Y. Yamamoto, Y. Yoshioka, T. Okamoto, S. Nakagawa, S. Nagata, and T. Mayumi Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting Nat. Biotechnol. 21 4 2003 399 404
12. A.L. De Boer, H. Van Urk, J.B. Bouwstra, P.F.T.M. Van Asten, Recombinant Gelatins. US Patent US2010/0119574 A1, 2008.
13. R.C. Chang, K.I. Kivirikko, T.B. Neff, D.R. Olsen, J.W. Polarek, US Patent US 6,992,172, B1, Jan, 31, 2006, 2006.
14. J.M. Phillips, and W.J. Kao Macrophage adhesion on gelatin-based interpenetrating networks grafted with PEGylated RGD Tissue Eng. 11 5-6 2005 964 973
15. Y. Ikada, and Y. Tabata Phagocytosis of bioactive microspheres J. Bioact. Compat. Polym. 1 1986 32 46
16. K. Eto, W. Puzon-McLaughlin, D. Sheppard, A. Sehara-Fujisawa, X.P. Zhang, and Y. Takada RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction J. Biol. Chem. 275 45 2000 34922 34930
17. A.P. Mould, A. Komoriya, K.M. Yamada, and M.J. Humphries The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues J. Biol. Chem. 266 6 1991 3579 3585
18. E. Ruoslahti RGD and other recognition sequences for integrins Annu. Rev. Cell Dev. Biol. 12 1996 697 715
19. E. Ruoslahti, and M.D. Pierschbacher New perspectives in cell adhesion: RGD and integrins Science 238 4826 1987 491 497
20. G.E. Davis Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites Biochem. Biophys. Res. Commun. 182 3 1992 1025 1031
21. L. Erb, J. Liu, J. Ockerhausen, Q. Kong, R.C. Garrad, K. Griffin, C. Neal, B. Krugh, L.I. Santiago-Perez, F.A. Gonzalez, H.D. Gresham, J.T. Turner, and G.A. Weisman An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction J. Cell Biol. 153 3 2001 491 501
22. M.H. Helfrich, S.A. Nesbitt, E.L. Dorey, and M.A. Horton Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin J. Bone Miner. Res. 7 3 1992 335 343
23. J.W. Smith, and D.A. Cheresh Integrin (alpha v beta 3)-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor J. Biol. Chem. 265 4 1990 2168 2172
24. V.A. Fadok, D.J. Laszlo, P.W. Noble, L. Weinstein, D.W. Riches, and P.M. Henson Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells J. Immunol. 151 1993 4274 4285
25. G. Berton, and C.A. Lowell Integrin signalling in neutrophils and macrophages Cell. Signal. 11 9 1999 621 635
26. E.J. Brown, and J.L. Goodwin Fibronectin receptors of phagocytes. Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes J. Exp. Med. 167 3 1988 777 793
27. H.D. Gresham, J.L. Goodwin, P.M. Allen, D.C. Anderson, and E.J. Brown A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis J. Cell Biol. 108 5 1989 1935 1943
28. K.S. Janardhan, G.D. Appleyard, and B. Singh Expression of integrin subunits alphav and beta3 in acute lung inflammation Histochem. Cell Biol. 121 5 2004 383 390
29. F.P. Lindberg, D.C. Bullard, T.E. Caver, H.D. Gresham, A.L. Beaudet, and E.J. Brown Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice Science 274 5288 1996 795 798
30. P.C. Brooks, R.A. Clark, and D.A. Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 5158 1994 569 571
31. R.C. Chang, K.I. Kivirikko, T.B. Neff, D.R. Olsen, J.W. Polarek, Recombinant gelatin. US Patent US 6,992,172, B1, Jan, 31, 2006, 2006.
32. S. Ishidoya, J. Morrissey, R. McCracken, A. Reyes, and S. Klahr Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction Kidney Int. 47 5 1995 1285 1294
33. T. Kawamura, E. Muso, T. Kamata, K. Suyama, A. Oyama, T. Ono, H. Yoshida, S. Miyawaki, and S. Sasayama Ultrastructural localization of dominantly increased fibronectin in the markedly thickened glomerular basement membrane in a selectively mated murine high IgA strain (HIGA mice) Nephron 83 2 1999 146 153
34. J.M. Alcazar, and J.L. Rodicio Ischemic nephropathy: clinical characteristics and treatment Am. J. Kidney Dis. 36 5 2000 883 893
35. J. Yamashita, S. Kita, T. Iwamoto, M. Ogata, M. Takaoka, N. Tazawa, M. Nishikawa, K. Wakimoto, M. Shigekawa, I. Komuro, and Y. Matsumura Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na+/Ca2+ exchanger J. Pharmacol. Exp. Ther. 304 1 2003 284 293
36. P.K. Chatterjee, K. Zacharowski, S. Cuzzocrea, M. Otto, and C. Thiemermann Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo FASEB J. 14 5 2000 641 651
37. R.B. Nagle, M.E. Johnson, and H.R. Jervis Proliferation of renal interstitial cells following injury induced by ureteral obstruction Lab. Invest. 35 1 1976 18 22
38. R.B. Nagle, R.E. Bulger, R.E. Cutler, H.R. Jervis, and E.P. Benditt Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes Lab. Invest. 28 4 1973 456 467
39. T. Kamata, F. Nogaki, S. Fagarasan, T. Sakiyama, I. Kobayashi, S. Miyawaki, K. Ikuta, E. Muso, H. Yoshida, S. Sasayama, and T. Honjo Increased frequency of surface IgA-positive plasma cells in the intestinal lamina propria and decreased IgA excretion in hyper IgA (HIGA) mice, a murine model of IgA nephropathy with hyperserum IgA J. Immunol. 165 3 2000 1387 1394
40. T. Makino, T. Ono, K. Matsuyama, F. Nogaki, S. Miyawaki, G. Honda, and E. Muso Suppressive effects of Perilla frutescens on IgA nephropathy in HIGA mice Nephrol. Dial. Transplant. 18 3 2003 484 490
41. F. Nogaki, E. Muso, I. Kobayashi, H. Kusano, K. Shirakawa, T. Kamata, A. Oyama, T. Ono, S. Miyawaki, H. Yoshida, and S. Sasayama Interleukin 12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition Nephrol. Dial. Transplant. 15 8 2000 1146 1154
42. L.P. Bartosik, G. Lajoie, L. Sugar, and D.C. Cattran Predicting progression in IgA nephropathy Am. J. Kidney Dis. 38 4 2001 728 735
43. G. D'Amico The commonest glomerulonephritis in the world: IgA nephropathy Q. J. Med. 64 245 1987 709 727
44. A.G. Gharavi, Y. Yan, F. Scolari, F.P. Schena, G.M. Frasca, G.M. Ghiggeri, K. Cooper, A. Amoroso, B.F. Viola, G. Battini, G. Caridi, C. Canova, A. Farhi, V. Subramanian, C. Nelson-Williams, S. Woodford, B.A. Julian, R.J. Wyatt, and R.P. Lifton IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23 Nat. Genet. 26 3 2000 354 357
45. S.C. Weight, P.R. Bell, and M.L. Nicholson Renal ischaemia-reperfusion injury Br. J. Surg. 83 2 1996 162 170
46. A.A. Bogdanov, R. Weissleder, and T.J. Brady Long-circulating blood pool imaging agents Adv. Drug Deliv. Rev. 16 2-3 1995 335 348
47. M.A. Lawson, and F.R. Maxfield Ca(2+)- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils Nature 377 6544 1995 75 79
48. J. Savill, I. Dransfield, N. Hogg, and C. Haslett Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis Nature 343 6254 1990 170 173